35.47 USD
↗ 1.34 (3.93%)AT CLOSE (11:59 AM EDT)
Harmony Biosciences Holdings, Inc. Common Stock
HRMYNASDAQ • USD
35.35
↘ 0.13 (0.35%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
35.35
↘ 0.13 (0.35%)
Market: CLOSED
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) trades at $35.47 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest HRMY is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 26, 2026.
Open?$34.13
High?$35.93
Low?$34.13
Prev. Close?$34.13
Volume?1.8M
Avg. Volume?781.2K
VWAP?$35.22
Rel. Volume?2.26x
Bid / Ask
Bid?$28.91 × 100
Ask?$41.46 × 100
Spread?$12.55
Midpoint?$35.19
Valuation & Ratios
Market Cap?2.1B
Shares Out?57.9M
Float?47.3M
Float %?82.1%
P/E Ratio?14.10
P/B Ratio?2.26
EPS?$2.52
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Themes
Employees
293
Market Cap
2.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-08-19
Address
630 W GERMANTOWN PIKE
PLYMOUTH MEETING, PA 19462
Phone: (484) 539-9800
PLYMOUTH MEETING, PA 19462
Phone: (484) 539-9800
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?99
Momentum?60
Short Sent.?70
Piotroski F-Score?3/9Weak
Altman Z-Score?5.35Safe
Confidence?57%Low
Short InterestHigh
Short % of Float?9.83%Elevated
Short Interest?4.6M
Days to Cover?5.2
Free Float47.3M
Avg Daily Volume894.8K
Settlement Date2026-06-15
Financial Health
Current Ratio?3.58Strong
Quick Ratio?3.56Strong
Cash Ratio?2.71Strong
Debt/Equity?0.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?14.1CHEAP▾
Peers100
S&P84
P/B?2.26CHEAP▾
Peers100
S&P69
P/S?2.28CHEAP▾
Peers100
S&P60
P/FCF?6.0CHEAP▾
Peers100
S&P97
EV/EBITDA?7.6CHEAP▾
Peers100
S&P92
EV/Sales?1.80CHEAP▾
Peers100
S&P79
Returns & Efficiency
ROE?16.0%STRONG▾
Peers50
S&P57
ROA?11.5%STRONG▾
Peers50
S&P79
Cash Flow & Enterprise
FCF?$341.8M
Enterprise Value?$1.6B
Fundamentals ratios updated end of day